Dr Mark Kris discusses the increasing precision of lung cancer therapies and the need for additional testing to find ...
"In our study, we showed that fine needle aspiration (FNA) biopsy material can be a good source for next-generation sequencing (NGS) for patients with metastatic prostate cancer. Based on these ...
Precision medicine is key to developing more effective and less toxic treatments, representing the present and future of oncology research. This approach offers significant promise for incremental ...
Children's Hospital Los Angeles (CHLA) and Thermo Fisher Scientific have agreed to develop a next-generation sequencing (NGS)-based panel designed specifically for pediatric cancer research. The assay ...
FT. MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics, Inc. (NASDAQ: NEO), a leading oncology testing services company, will present four abstracts at the Association for Molecular Pathology (AMP) 2024 Annual ...
Gene Solutions and Pangea Laboratory Establish Strategic Collaboration to Validate Laboratory Developed ctDNA Tests for ...
Pangea Laboratory collaborates with Gene Solutions to advance cancer diagnostics in United States: Irvine, California Saturday, January 24, 2026, 12:00 Hrs [IST] Pangea Laboratory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results